Evernorth Health Services has introduced Evernorth Oncology Benefit Services, which will be available to eligible commercial plan sponsors in 2025, with plans to expand over time.

Researchers have identified sleep apnea as a common comorbidity among patients with cardiodiabesity.

The clinical efficacy of a drug must always take priority over any other considerations when developing formularies.

SDOH are shown to contribute as much as 80 percent to a person’s health versus clinical care, which is only 20 percent.

To better understand how socioeconomic disparities impact breast cancer screening and care, the Evernorth Research Institute analyzed claims data of more than 168,000 women covered by commercial health insurance, Medicaid, or Medicare.

Reinforcing Commitment to Health and Value While Improving Provider Experience